HC
BIO icon

Hara Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hara Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$875K Sell
2,981
-5
-0.2% -$1.42K 0.46% 54
2026
Q1 		$832K Buy
2,986
+183
+7% +$52.7K 0.42% 58
2025
Q4 		$849K Sell
2,803
-452
-14% -$141K 0.47% 52
2025
Q3 		$913K Buy
+3,255
New +$886K 0.54% 42

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hara Capital's BIO Position: Q2 2026 in Review

Hara Capital reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.17% in Q2 2026, selling an estimated $1.42K and leaving 2,981 shares worth $875K. The position accounts for 0.46% of the portfolio, ranked #54.

Hara Capital first reported a position in BIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $913K in Q3 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Hara Capital held 2,981 shares of Bio-Rad Laboratories Class A worth $875K as of Q2 2026.
  • Hara Capital sold 5 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.42K.
  • Bio-Rad Laboratories Class A made up 0.46% of Hara Capital's portfolio in Q2 2026, its #54 holding.
  • Hara Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 4 quarters since.
  • Hara Capital's Bio-Rad Laboratories Class A position peaked at $913K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.